Back
Ikena Oncology 10K Form
Sell
36
IKNA
Ikena Oncology
Last Price:
1.70
Seasonality Move:
7.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IKNA News And Ratings
See the #1 stock for the next 7 days that we like better than IKNA
IKNA Financial Statistics
Sales & Book Value
| Annual Sales: | $9.16M |
|---|---|
| Cash Flow: | $-8.94M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.78 |
| Price / Book: | 0.61 |
Profitability
| EPS (TTM): | -1.22000 |
|---|---|
| Net Income (TTM): | $-59.6M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Ikena Oncology Earnings Forecast
Key Ikena Oncology Financial Ratios
- The Research & Development expenses have been 651.22% of Revenue.
- The Net Earning history of IKNA is -744.17% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Ikena Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | IKNA |
| Website: | ikenaoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IKNA Technical Analysis vs Fundamental Analysis
Sell
36
Ikena Oncology (IKNA)
is a Sell
Is Ikena Oncology a Buy or a Sell?
-
Ikena Oncology stock is rated a Sell
The current Ikena Oncology [IKNA] share price is $1.71. The Score for IKNA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.